SG Americas Securities
VOR icon

SG Americas Securities’s Vor Biopharma VOR Stock Holding History

SG Americas Securities’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-659
Closed -$31K – 3343
2024
Q1 		$31K Sell
659
-406
-38% -$17.8K ﹤0.01% 2834
2023
Q4 		$48K Buy
1,065
+202
+23% +$8.34K ﹤0.01% 2929
2023
Q3 		$37K Buy
+863
New +$46.8K ﹤0.01% 2989
2021
Q4 		– Sell
-543
Closed -$170K – 3841
2021
Q3 		$170K Buy
+543
New +$161K ﹤0.01% 3339

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities's VOR Position: Q2 2024 in Review

SG Americas Securities sold out of Vor Biopharma (VOR) in Q2 2024, closing a stake of 659 shares — an estimated $31K sold.

SG Americas Securities first reported a position in VOR in Q3 2021 and held it in 4 quarters. The position peaked at $170K in Q3 2021. 71 funds tracked by Wall St. Rank hold VOR as of Q2 2024.

  • SG Americas Securities reported no remaining Vor Biopharma position as of Q2 2024 after selling out during the quarter.
  • SG Americas Securities sold 659 Vor Biopharma shares in Q2 2024, an estimated $31K.
  • SG Americas Securities first reported a position in Vor Biopharma in Q3 2021 and held it in 4 quarters.
  • SG Americas Securities's Vor Biopharma position peaked at $170K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2024.

Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.